The AstraZeneca Annual Business review took place on Wednesday 6th October 2004.
Press Release and Pipeline table Press Release - 73 kb R&D Pipeline Summary - 56 kb
Presentations Introduction - 955 kb Exanta - 1,101 kb Discovery/Early Pipeline - 2,022 kb Cardiovascular - 2,433 kb Oncology - 1,678 kb Nexium - 1,220 kb Symbicort - 1,735 kb Seroquel - 2,612 kb Emerging Markets - 2,333 kb
Online order formTel: +44 (0)1707 256 677
Receive an email alert each time a presentation is added to this page
Acrobat® PDF Reader (external link)